Survey on Knowledge about Thyroid Nodules and Differentiated Thyroid Cancer among General Practitioners in Pudong New Area of Shanghai
Department of General Medicine,Jinyang Community Health Service Center,Pudong New Area,Shanghai 200136,China
*Corresponding author: ZHANG Tao,Chief physician;E-mail: songdp201206@126.com
TANG Huiyun,ZHANG Tao,SHA Jingjing, et al. Survey on Knowledge about Thyroid Nodules and Differentiated Thyroid Cancer among General Practitioners in Pudong New Area of Shanghai [J]. Chinese General Practice, 2020, 23(17): 2207-2214. DOI: 10.12114/j.issn.1007-9572.2020.00.067.
唐慧芸,张韬,沙婧婧等. 上海市浦东新区全科医生甲状腺结节及分化型甲状腺癌相关知识了解情况调查[J]. 中国全科医学, 2020, 23(17): 2207-2214. DOI: 10.12114/j.issn.1007-9572.2020.00.067.
[1]滕卫平,刘永锋,高明,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272.http://www.cnki.com.cn/Article/CJFDTotal-ZGZL201217004.htm.
[2]陈国庆,徐英杰,谢江,等.甲状腺结节的社区筛检干预与临床规范治疗的研究[J].现代预防医学,2012,39(22):5855-5856,5859.
CHEN G Q,XU Y J,XIE J,et al.Thyroid nodules community screening interventions and clinical standard treatment practices for research[J].Modern Preventive Medicine,2012,39(22):5855-5856,5859.
[3]王深明,李梓伦.重视甲状腺结节的正确评估和随访[J].中国实用外科杂志,2010,30(S1):1-4.
WANG S M,LI Z L.Attach importance to the appropriate evaluation and follow-up of thyroid nodules[J].Chinese Journal of Practical Surgery,2010,30(S1):1-4.
[4]国家卫生计生委,国家中医药管理局.乳腺癌和甲状腺癌分级诊疗重点任务及服务流程图[EB/OL].(2017-02-09)[2019-02-20].http://www.nhc.gov.cn/yzygj/s3594q/201702/0c46c23dc2694973bb5bea8060f1ccff.shtml.
[5]GHARIB H,PAPINI E,GARBER J R,et al.American Association of Clinical Endocrinologists,American College of Endocrinology,and Associazione Medici Endocrinologi Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update[J].Endocr Pract,2016,22(5):622-639.DOI:10.4158/EP161208.GL.
[6]中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华核医学与分子影像杂志,2013,33(2):96-115.DOI:10.3760/cma.j.issn.2095-2848.2013.02.003.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhhyX201302003.
[7]张丽丽.彩色多普勒超声检查对甲状腺结节良恶性的诊断意义[J].影像研究与医学应用,2018,2(23):107-108.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xlys-x201616011.
[8]侯浩宇,杨金君,贾崴.50例甲状腺结节良恶性患者行64层螺旋CT扫描影像特点的回顾性分析[J].中国CT和MRI杂志,2016,14(11):13-15.DOI:10.3969/j.issn.1672-5131.2016.11.005.
HOU H Y,YANG J J,JIA W.Retrospective analysis of 64 slice spiral CT imaging features of 50 patients with benign and malignant thyroid nodules[J].Chinese Journal of CT and MRI,2016,14(11):13-15.DOI:10.3969/j.issn.1672-5131.2016.11.005.
[9]王治国,武晓丹,战莹,等.甲状腺乳头状癌18 F-FDG PET/CT显像葡萄糖代谢与BRAF突变的相关性研究[J].实用肿瘤学杂志,2017,31(6):519-523.DOI:10.11904/j.issn.1002-3070.2017.06.007.
WANG Z G,WU X D,ZHAN Y,et al.The correlation between glucose metabolism and BRAF mutation in 18 F-FDG PET/CT imaging of papil-lary thyroid carcinoma[J].Practical Oncology Journal,2017,31(6):519-523.DOI:10.11904/j.issn.1002-3070.2017.06.007.
[10]HAUGEN B R,ALEXANDER E K,BIBLE K C,et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133.DOI:10.1089/thy.2015.0020.
[11]严丽,李情怀,王树峰,等.术前TSH水平与甲状腺结节良恶性关系[J].中国普通外科杂志,2012,21(11):1373-1376.
YAN L,LI Q H,WANG S F,et al.Relationship between preoperative serum thyrotropin(TSH) level and the nature of thyroid nodule[J].Chinese Journal of General Surgery,2012,21(11):1373-1376.
[12]吕坤祥,宋智明,朱利国,等.促甲状腺激素、甲状腺球蛋白浓度在甲状腺良、恶性结节诊断中的价值[J].标记免疫分析与临床,2014,21(1):74-76.DOI:10.11748/bjmy.issn.1006-1703.2014.01.023.
LYU K X,SONG Z M,ZHU L G,et al.Diagnostic value of serum thyroid stimulating hormone and thyro globulin levels in differentiating thyroid benign and malignant nodules[J].Labeled Immunoassays and Clinical Medicine,2014,21(1):74-76.DOI:10.11748/bjmy.issn.1006-1703.2014.01.023.
[13]JENDRZEJEWSKI J,HE H L,RADOMSKA H S,et al.The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type[J].Proc Natl Acad Sci USA,2012,109(22):8646-8651.DOI:10.1073/pnas.1205654109.
[14]蔡文松,徐波.甲状腺结节的评估和治疗选择[J].临床外科杂志,2017,25(11):820-822.DOI:10.3969/j.issn.1005-6483.2017.11.006.http://www.cnki.com.cn/Article/CJFDTotal-LCWK201711006.htm.
[15]MIYAMOTO Y,HAYASHI N,SAKAMOTO Y,et al.Predictors of long-term survival in patients with stage Ⅳ colorectal cancer with multi-organ metastases:a single-center retrospective analysis[J].Int J Clin Oncol,2015,20(6):1140-1146.DOI:10.1007/s10147-015-0835-2.
[16]SEO S H,KANG M S,KIM K H,et al.Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma[J].Int J Surg,2015,13:96-101.DOI:10.1016/j.ijsu.2014.10.009.
[17]PASCHKE R,LINCKE T,MüLLER S P,et al.The treatment of well-differentiated thyroid carcinoma[J].Deutsches Aerzteblatt Online,2015,112(26):452-458.DOI:10.3238/arztebl.2015.0452.